Adam R. Nasar (he/him/his)

Analytical Development Scientist
Labcorp, United Kingdom

I am a Research and Development Scientist within BioCMC for Labcorp Early Development based in York, UK.
My main area of focus is around developing an analytical toolkit for biopharmaceutical products such as vaccines and antigen formulations with focus on CE and LC modalities.

Poster(s):

• (W1230-01-05) Development of a Marburg Self-amplifying mRNA-Lipid Nanoparticle Vaccine: Differential Effects When Co-formulated with Toll Receptor Agonists
  Wednesday, May 15, 2024

  12:30 PM – 1:30 PM PT

• (T1330-01-02) Formulation Development and Characterization of a Marburg Self-amplifying mRNA-Lipid Nanoparticle Vaccine with a Toll-Like Receptor 7 Agonist
  Tuesday, May 14, 2024

  1:30 PM – 2:30 PM PT

• (T1530-02-11) Formulation Development and Characterization of a Marburg Self-amplifying mRNA-Lipid Nanoparticle Vaccine with CpG Oligonucleotide
  Tuesday, May 14, 2024

  3:30 PM – 4:30 PM PT